EmbR is a transcriptional regulator that is phosphorylated by the cognate mycobacterial STPK (serine/threonine protein kinase) PknH. Recent studies demonstrated that PknH-dependent phosphorylation of EmbR enhances its DNA-binding activity and activates the transcription of the embCAB genes encoding arabinosyltransferases, which participate in arabinan biosynthesis. In the present study, we identified a genomic region of 4425 bp, which is present in Mycobacterium tuberculosis CDC1551, but absent from M. tuberculosis H37Rv, comprising the MT3428 gene, which is homologous with embR. Homology modelling of the MT3428 gene product illustrated its close relationship (56 % identity) to EmbR, and it was hence termed EmbR2. In marked contrast with EmbR, EmbR2 was not phosphorylated by PknH, although it is a substrate of other M. tuberculosis kinases, including PknE and PknF. Tryptophan fluorescence emission of EmbR2 was monitored in the presence of three different PknH-derived phosphopeptides and demonstrated that EmbR2 binds to at least two of the threonine sites known to undergo autophosphorylation in PknH. We observed that the capacity of EmbR2 to interact physically with PknH without being phosphorylated was a result of EmbR2-mediated inhibition of kinase activity: incubation of PknH with increasing concentrations of EmbR2 led to a dose-response inhibition of the autokinase activity, similarly to O 6 -cyclohexylmethylguanine, a known inhibitor of eukaryotic cyclin-dependent kinases. Moreover, EmbR2 inhibited PknH-dependent phosphorylation of EmbR in a dose-dependent manner. Together, these results suggest that EmbR2 is a regulator of PknH activation, thus directly participating in the control of the PknH/EmbR pair and potentially in mycobacterial physiology/virulence of M. tuberculosis CDC1551.
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INTRODUCTION
Genes encoding functional STPKs (serine/threonine protein kinases) are ubiquitous in prokaryotic genomes, but little is known regarding their physiological substrates and their participation in bacterial signal-transduction pathways and their regulation. Based on their genomic context, many of the 11 STPKs from Mycobacterium tuberculosis were proposed to participate in regulation of diverse physiological functions [1] . An increasing body of evidence indicates that the STPKs play important roles in the physiology and virulence of M. tuberculosis and are potential therapeutic targets for future drug development against tuberculosis [2] . Recent studies have provided evidence that at least two kinases, PknG and PknH, play a role in the virulence of M. tuberculosis [3] [4] [5] . PknG contributes to the survival of mycobacteria within macrophages by preventing the fusion of phagosomes with lysosomes [5] . In contrast, it was demonstrated that a PknH mutant of M. tuberculosis is hypervirulent in infected mice, and it was proposed that PknH regulates intracellular bacterial growth, particularly during the chronic phase [4] .
Since EmbR (Rv1267c) and the sensor-like serine/threonine kinase PknH (Rv1268c) are adjacent in the M. tuberculosis genome, we first investigated whether EmbR may represent an endogenous substrate of PknH. We found that EmbR was phosphorylated by PknH in vitro and that the interaction with the kinase was mediated by EmbR's C-terminal FHA (forkheadassociated) domain [6] . FHA domains are small protein modules capable of mediating protein-protein interactions through P-Thr (phosphothreonine) recognition, and often participate in proteinprotein interactions in STPK-dependent signal-transduction pathways [7] . Truncation of the EmbR FHA domain or point mutations altering conserved residues in the P-Thr-binding pocket dramatically diminished PknH-mediated threonine phosphorylation of EmbR [6] . Elucidation of the three-dimensional structure of EmbR revealed that, in addition to the FHA domain, it possesses two major domains, an N-terminal winged helix-turnhelix DNA-binding domain followed by a central BTA (bacterial transcription activation) domain, suggesting that EmbR may act as a transcriptional regulator in M. tuberculosis [8] . This was recently supported by the fact that phosphorylation of EmbR enhances its DNA-binding activity towards promoter regions of embCAB genes [9] . The corresponding gene products are known to participate in the biosynthesis of arabinogalactan and LAM (lipoarabinomannan), which are critical components of the mycobacterial cell wall [10] [11] [12] . The PknH-mediated increase in transcription of embAB also alters resistance to ethambutol, a frontline antituberculosis drug known to target embAB [10, 11] . These results, along with the in vivo up-regulation of PknH inside host macrophages [13] , suggest a functionally relevant signalling mechanism involving the PknH-EmbR-EmbCAB components.
In addition, Sharma et al. [9] demonstrated that the STPKs PknA and PknB also regulate the signalling pathway leading to EmbR phosphorylation.
In a related actinomycete, Corynebacterium glutamicum, phosphoproteome studies experimentally determined 120 unique serine/threonine-phosphorylated proteins that are phosphorylated by only four STPKs [14] . In support of these results, using a bioinformatics approach, 40 potential PknH substrates were identified (including EmbR) in M. tuberculosis, and two of the newly predicted substrates were experimentally shown to be phosphorylated by PknH in vitro [15] . These two substrates, which lack an FHA domain, are Rv0681, a TetR-class transcription factor, and DacB1, a penicillin-binding protein [15] . The presence of a large number of FHA-and non-FHA-containing substrates of PknH in M. tuberculosis suggests a possible participation of this kinase in numerous signalling pathways. Since PknH appears as a key determinant of pathogen virulence [4] , it is very likely that further characterization of the various endogenous substrates and regulatory mechanisms will increase our understanding of the physiology and pathogenicity of M. tuberculosis. One possible mechanism of regulating the phosphosignalling responses is to control the rate of phosphorylation of both the kinases and the substrates, which can be achieved in vitro and in vivo by serine/threonine phosphatases. To date, only one serine/threonine phosphatase, termed PstP, has been found in the M. tuberculosis genome mediating dephosphorylation of kinases [16] as well as substrates [17] . However, it is unlikely that PstP represents the only factor that controls the phosphorylation status of all 11 STPKs and all substrates in vivo. We reasoned that additional mechanisms of controlling/regulating the phosphorylation status of PknH might exist. In Streptomyces coelicolor A3(2), the KbpA protein that is involved in actinorhodin production has been demonstrated to bind to the STPK AfsK and to inhibit its autophosphorylation activity at serine and threonine residues [18] . KbpA also inhibited phosphorylation of AfsR, which is the substrate of AfsK, presumably because KbpA inhibited the conversion of AfsK from the inactive non-phosphorylated form into the active phosphorylated form [18] .
In light of this study, we extended our previous work on the characterization of the PknH/EmbR pair by identifying and characterizing a protein from M. tuberculosis CDC1551 that interferes specifically with the autokinase activity of PknH, subsequently inhibiting PknH-dependent phosphorylation of EmbR. This protein, termed EmbR2, closely related to EmbR, is capable of interacting with PknH, but cannot be phosphorylated by this kinase. We predict that this protein would represent a bait for PknH and may represent a novel mechanism of regulation of the PknH/EmbR couple.
MATERIALS AND METHODS

Bacterial strains, plasmids and growth conditions
Overproduction of EmbR2 was performed in Escherichia coli strain C41(DE3) [19] . E. coli TOP-10 (Invitrogen) was used to propagate plasmids in cloning experiments. All strains were grown and maintained at 37
• C in LB (Luria-Bertani) medium supplemented with either 25 µg/ml kanamycin or 100 µg/ml ampicillin, when required. Plasmids pET28a and pCR-BluntII-TOPO were purchased from Novagen and Invitrogen respectively.
Expression and purification of GST (glutathione transferase)-tagged STPKs from M. tuberculosis
Plasmids designed to express the eight catalytic domains of STPKs (PknA, PknB, PknD, PknE, PknF, PknH, PknK and PknL) fused to GST were constructed by PCR amplification by using M. tuberculosis H37Rv genomic DNA as a template as described previously [17] . Kinases were purified using glutathione-Sepharose 4B matrix as reported previously [17] .
Expression and purification of a His 6 -tagged EmbR and EmbR2
Construction of pET28a-embR expression vector was used to overproduce EmbR in C41(DE3) E. coli cells as reported previously [6] . The embR2 gene (MT3428), with appropriate sites at both ends, was synthesized by PCR amplification by using M. tuberculosis CDC1551 genomic DNA as a template and the following primers: embR2-up 5 -CCCATATGGCCCGAAACGAA-CTCCG-3 (NdeI site underlined) and embR2-lo 5 -GGATCC-TAACGGCCCGATTCGTG-3 (BamHI site underlined). This 1156-bp DNA fragment was directly ligated into the pCR-BluntII-TOPO, yielding the pCRII-BluntII-embR2 construct. The embR2 insert was then extracted and purified following restriction of pCRII-BluntII-embR2 with NdeI and BamHI and subsequently ligated into the NdeI/BamHI-restricted pET28a, thus giving rise to pET28a-embR2, which was used to transform E. coli C41(DE3) cells. Cultures were incubated at 37
• C under shaking until the D 600 (attenuance at 600 nm) reached 0.5. IPTG (isopropyl β-Dthiogalactoside) was then added at a final concentration of 1 mM, and growth was continued for an additional 3 h at 30
• C. Cells were harvested by centrifugation at 6000 g for 10 min, washed in 10 ml of buffer A [50 mM Tris/HCl, pH 7.5, 150 mM NaCl, 10 % (v/v) glycerol, 1 mM 2-mercaptoethanol, 1 mM EDTA and 10 mM imidazole] containing DNase, RNase and a protease inhibitor cocktail (Roche). Bacteria were then disrupted in a French pressure cell and the resulting extract was centrifuged at 27 000 g for 30 min at 4
• C. The supernatant was collected and incubated for 2 h at 4
• C on a rotating wheel with Ni-NTA (Ni 2+ -nitrilotriacetate)-agarose (Qiagen) previously equilibrated with buffer A. After extensive washing with buffer A, bound proteins were eluted with elution buffer (50 mM Tris/HCl, pH 7.5, 150 mM NaCl, 10 % glycerol, 1 mM 2-mercaptoethanol, 1 mM EDTA and 300 mM imidazole). Pure EmbR2 fractions were pooled, dialysed against 50 mM Tris/HCl (pH 7.5), 150 mM NaCl, 10 % glycerol, 1 mM 2-mercaptoethanol and 1 mM EDTA to remove imidazole and stored at -20
• C until further use.
Site-directed mutagenesis
Site-directed mutagenesis was carried out based on PCR amplification. A first set of PCR amplifications was generated using pET28a-embR2 as a template along with the primer pair, number 428 (5 -GCCCTGTGGACGCAACTCATCACC-GCATACTAT-3 ) and number 431 (5 -TATGGATCCCTAACGG-CCCGATTCGTGCGG-3 ), to generate embR2-R204T/A208T. This PCR product was then used as a primer in a second round of PCR amplification in combination with primer number 430 (5 -TAATAGCTCATATGGCCCGAAACGAACTCCGGTTC-3 ) to generate the entire 1146-bp embR2 gene. This DNA fragment, containing the appropriate sites at both ends, was restricted by NdeI and BamHI (sites italicized) and ligated in the NdeI/BamHIrestricted pET28a, generating pET28a-embR2-R204T/A208T. The nucleotide changes in the different primers to allow specific amino acid replacement are underlined. Mutations were verified by DNA sequencing. The His-tagged EmbR2 mutant protein was overexpressed and purified as described above.
In vitro kinase assay
In vitro phosphorylation of approx. • C. In vitro inhibition assays were carried out with 0.5-3 µg of EmbR2 (0.55-3.3 µM) or with 5-100 µM of O 6 -cyclohexylmethylguanine. The reaction was stopped by addition of an equal volume of 2 × sample buffer and the mixture was heated at 100
• C for 5 min. After electrophoresis, gels were soaked in 16 % (v/v) trichloroacetic acid for 10 min at 90
• C, dried and exposed to a film. Intensity of the radioactivity was measured with a Molecular Dynamics Typhoon PhosphorImager.
Phosphopeptide-binding assay
Intrinsic tryptophan-fluorescence emission was measured between 300 and 400 nm (scan speed 100 nm/min), using a PerkinElmer Luminescence Spectrometer LS 50B, exciting the sample at a wavelength of 295 nm. Spectra were recorded for each peptide aliquot (1 µl) added to 400 µl of a 5 µM solution of EmbR2, until reaching a final peptide concentration of 0.5 mM (11 additions). A plot of the fluorescence intensity at 330 nm against the peptide concentration (three independent experiments) resulted in a binding isotherm that was fitted to a one-site saturation model (SigmaPlot; Systat Software).
Analysis of the phospho-amino acid content of proteins
Phospho-amino acid analysis of the EmbR or EmbR2 proteins labelled in vitro with PknE, PknF or PknH was performed as previously described [20] .
Homology model of EmbR2
A homology model of the molecular structure of Mt-CDC1551 EmbR2 was derived based on the crystal structure of EmbR bound to the phosphopeptide SLEVpTEADT [8] . Models were obtained from several Web-based modelling servers, including SWISS-MODEL [21] , Geno3D [22] and 3D-JIGSAW [23] . The homology models were analysed in comparison with the chain A complex of the phosphopeptide-bound structure of EmbR (PDB entry 2FF4 [8] ).
Synthesis of O 6 -cyclohexylmethylguanine
The target sample was prepared by the method of Arris et al. [24] . Chloroform/methanol (20:1, v/v) was used for purification via silica-gel column chromatography, yielding a single spot on TLC: white solid, yield 66 %, m.p. (melting point) 202-204 
RESULTS AND DISCUSSION
Identification of EmbR2 in M. tuberculosis CDC1551
In the present study, we extended our previous studies by deciphering a new mechanism of regulation of phosphorylation of EmbR by PknH. To this end, we first explored the genome of M. tuberculosis strain CDC1551 that, in contrast with the laboratory strain M. tuberculosis H37Rv, is involved in a recent cluster of tuberculosis cases and is known to be transmissible and virulent in humans [25] . The CDC1551 strain appears to be highly infectious in humans, is comparable in virulence with strain H37Rv in animal models [26] and has greater immunoreactivity than H37Rv and other clinical strains due to increased induction of TNFα (tumour necrosis factor α), IL-6 (interleukin-6), IL-10 and IL-12 [27] . We identified a genomic region of 4425 bp that is present in CDC1551, but absent from M. tuberculosis strain H37Rv, comprising the MT3428 gene [28] ( Figure 1A) . The insertion sequence IS6110 is the principal epidemiological marker for M. tuberculosis. A number of the insertions and deletions were associated with this insertion sequence, suggesting a role for this element in genome plasticity [29] . The presence in H37Rv of IS6110 lacking the 3-4-bp direct repeat directly adjacent to the deleted region relative to strain CDC1551 indicates that this deletion was associated with a possible mechanism of homologous recombination between nearby IS6110 elements [30] . We also found the MT3428 gene in other mycobacterial species, including Mycobacterium bovis and M. bovis BCG (Bacille Calmette-Guérin) (results not shown). MT3428, annotated as a putative transcriptional regulator, is highly homologous with EmbR. Indeed, the amino acid sequences of M. tuberculosis H37Rv EmbR and M. tuberculosis CDC1551 MT3428 (termed EmbR2) align with 55 % sequence identity over 381 residues (alignment using ClustalW; Figure 1B ). The alignment is almost free from insertions and deletions. A singleresidue gap in the FHA domain of EmbR2 maps to residue 300 (EmbR), whereas an N-terminal 5-residue deletion is located within the first eight residues in the sequence. In contrast with embR, which is genetically linked to pknH [6, 31] , embR2 is found to be genetically distant from pknH.
We have generated homology models of EmbR2 based on our recently determined high-resolution X-ray crystal structure of EmbR [8] . This seemed justified based on the high level of sequence identity and the very good resolution of the template structures (PDB entry 2FEZ: 2.0 Å; PDB entry 2FF4: 1.9 Å; 1 Å = 0.1 nm). Algorithm-specific bias of the modelling outcome was minimized by generating models using a range of modelling servers. As expected, all models display a conserved backbone conformation for the N-terminal DNA-binding domain, the central BTA domain and the C-terminal FHA domain ( Figure 1C ). The models only diverge slightly around residue 294, where the FHA domain of EmbR2 lacks a residue relative to EmbR. This model clearly confirms the characterization of EmbR2 as a structural homologue of EmbR. We therefore addressed the question whether cross-regulation/interaction between these two proteins with PknH would occur.
EmbR2 is not phosphorylated by PknH
We first investigated whether EmbR2 represents a substrate of PknH. To this end, PknH was expressed as a GST fusion [6] , whereas EmbR and EmbR2 were expressed and purified as His-tagged fusions. When incubated with purified EmbR in the presence of [γ -
33 P]ATP, PknH was able to phosphorylate EmbR, consistent with our previous results (Figure 2 ) [6] . In stark contrast, EmbR2 was not phosphorylated by PknH in vitro (Figure 2 ). This was rather unexpected, given the high degree of sequence and structural conservation between these two proteins, an identical domain organization and invariance of three key residues in the FHA domain (Arg 312 , Ser 326 and Asn 348 ) that are required for recognition of EmbR by PknH [6] .
In their attempt to identify endogenous substrates of the PknH kinase, Zheng et al. [15] searched the M. tuberculosis genome database for open reading frames containing sequences similar to the motif TQLGT, which encompasses a site of autophosphorylation in the activation loop of PknH, reasoning that the autophosphorylation and kinase activity may target similar amino acid motifs [15] . This allowed the identification of 40 putative substrates, including EmbR (containing a TQLIT motif), Rv0681 (containing a TQLGT motif) and DacB1 (containing a TQIGT motif). Replacement of the first threonine residue in this motif
Figure 2 In vitro phosphorylation of EmbR and EmbR2 by PknH
His-tagged fusion proteins were purified from E. coli C41(DE3) carrying pET28a-embR, pET28a-embR2 or pET28a-embR2(R204T/A208T). Purified GST-PknH was incubated with 3 µg of purified His-tagged EmbR, EmbR2 or EmbR2-R204T/A208T in the presence of [γ - 33 P]ATP for 15 min at 37 • C. Samples were separated by SDS/PAGE and detected by Coomassie Brilliant Blue staining (upper panels) and then exposed overnight to a film and visualized by autoradiography (lower panels). Positions of PknH, EmbR and EmbR2 are indicated.
by an alanine residue completely abolished Rv0681 phosphorylation by PknH, whereas in the case of EmbR and DacB1, phosphorylation by PknH was significantly reduced compared with the wild-type proteins [15] . EmbR2 contains a RQLIA motif instead of the TQLIT motif present in EmbR ( Figure 1B) . To investigate the possibility that absence of phosphorylation of EmbR2 by PknH correlates with the lack of the TQLIT motif, both the Arg 204 and Ala 208 were simultaneously replaced by two threonine residues to restore a genuine TQLIT motif within EmbR2. However, when tested in the presence of [γ - 33 P]ATP, PknH still failed to phosphorylate the EmbR2-R204T/A208T mutant ( Figure 2 ). This indicates that the lack of a TQLGT motif in EmbR2 is not responsible for the absence of phosphorylation by PknH.
STPK-mediated phosphorylation of EmbR and EmbR2
Overlapping substrate specificity of different M. tuberculosis kinases has been reported previously [17, 32, 33] . This prompted us to investigate whether EmbR2 could be phosphorylated by other M. tuberculosis STPKs. EmbR2 was found to be phosphorylated by PknE and PknF ( Figure 3A) . Whereas PknF phosphorylates EmbR and EmbR2 equally well, PknE preferentially phosphorylates EmbR over EmbR2. In marked contrast, PknH is unable to phosphorylate EmbR2, but phosphorylates EmbR, similarly to PknE/F. This suggests different levels of substrate specificity of 33 P]ATP, analysed by SDS/PAGE, electroblotted on to an Immobilon PVDF membrane, excised and hydrolysed in acid. The phospho-amino acids thus liberated were separated by electrophoresis in the first dimension (1D) and ascending chromatography in the second dimension (2D). After migration, radioactive molecules were detected by autoradiography. Authentic phosphoserine (P-Ser), phosphothreonine (P-Thr) and phosphotyrosine (P-Tyr) were run in parallel as internal standard controls and visualized by ninhydrin staining.
the different STPKs. A corollary, arising from these experiments, is that EmbR and EmbR2, as they interact with multiple STPKs, may be regulated by multiple signals. Although a complex network of interactions between EmbR/EmbR2 and the different STPKs may exist, it remains to be established whether this STPK cross-talk occurs in vivo.
We next analysed the nature of the phosphorylated amino acid residues in EmbR/EmbR2 after in vitro phosphorylation with PknE, PknF or PknH. Following incubation with the kinases and [γ -33 P]ATP, labelled proteins were separated by SDS/ PAGE, excised and subjected to acid hydrolysis. Figure 3(B) shows that, in agreement with our previous results [6] , EmbR was phosphorylated by PknH only on threonine residues. However, analysis of the phospho-amino acid content of PknE-phosphorylated EmbR revealed that phosphorylation occurs on both threonine and serine residues, whereas PknF phosphorylated EmbR only on serine residues. These unexpected results prompted us to explore the phospho-amino content of the different Pkn/ EmbR2 couples. Whereas EmbR2 was preferentially phosphorylated at threonine residues in the presence of PknE (with minor amounts of phosphoserine being detected), it was mainly phosphorylated at serine residues in the presence of PknF. As for EmbR, these results show that the nature of the phosphorylation sites is kinase-dependent. Furthermore, comparison of the phospho-amino profiles of EmbR and EmbR2 in relation to the different kinases also revealed that the nature of the phosphorylation sites is also dependent on the substrate. PknF phosphorylates EmbR strictly at serine residues, whereas PknF phosphorylates EmbR2 at both serine and threonine residues.
Physical interaction between EmbR2 and PknH-derived phosphopeptides
PknH was shown to possess autokinase activity on nine serine and threonine residues [6, 34] , and one of the threonine sites located within the kinase activation loop, Thr 170 , is required for PknH-mediated phosphorylation of EmbR [6] . As EmbR2 contains three tryptophan residues, we assessed ligand binding by intrinsic tryptophan fluorescence. Intensity of tryptophan fluorescence emission at 330 nm was monitored as a function of the concentration of three different PknH-derived phosphopeptides (DEKLpTQLGT containing the P-Thr 170 , TQLGpTAVGT containing the P-Thr 174 and DSAGpTLVSS containing the PThr 222 ), as well as using a non-specific phosphopeptide derived from the high-affinity ligand of the FHA domain of the yeast Rad53p checkpoint kinase [7] (SLEVpTEADT). Changes in the emission intensity at 330 nm with increasing peptide concentrations reflect ligand binding, and the equilibrium dissociation constant K d can be derived by fitting the resulting binding isotherm ( Table 1) . Each of the phosphopeptides bound with an equilibrium dissociation constant (K d ) in the order of 15 µM. This is in marked contrast with binding data obtained with EmbR, where only the Rad53p-derived peptide caused a measurable change in the emission signal, indicating a K d of approx. 175 µM [8] . Therefore these results suggest that EmbR2 binds to at least two of the threonine sites known to undergo autophosphorylation in PknH [34] .
Overall, the absence of PknH-mediated phosphorylation of EmbR2, despite low-micromolar interaction of the latter with at least three likely docking sites on the kinase, led us to hypothesize that EmbR2 may act not as a substrate of PknH but rather as an inhibitor.
Selective inhibitory effect of O 6 -cyclohexylmethylguanine on M. tuberculosis kinases
Cyclin-dependent kinases are increasingly recognized as important targets for therapeutic intervention in various proliferative disease states, including cancer [35] . O 6 -cyclohexylmethylguanine has been reported as a newly discovered ATP-competitive purine-based inhibitor of CDK1 (cyclin-dependent kinase 1)/ cyclin B1 and CDK2/cyclin A3, the O 6 substituent occupying the kinase ribose-binding sites [24, 36] . Notably, screening of a small library of approx. 5000 compounds from Southern Research through the TAACF (Tuberculosis Antimicrobial Acquisition and Coordinating Facility; http://www.taacf.org) identified a small number of 6-alkylthio-and O 6 -alkyl purine residues as well as 2,4-disubstituted and 2,4,6-trisubstituted pyrimidine residues that were relatively active compared with M. tuberculosis H37Rv in vitro [37] . A cheminformatic search of the scaffolds suggested that these simple analogues may be ATP-competitive inhibitors of signalling kinases in M. tuberculosis. Recent publications support that these purine and pyrimidine scaffolds show broad and excellent antitubercular activity [38] [39] [40] and, in certain cases, antibacterial and enzymatic activities compared with ATPrequiring bacterial kinases. Preliminary screening of several active samples from the TAACF in vitro screen identified the reported ATP-competitive CDK inhibitor O 6 -cyclohexylmethylguanine as a potential inhibitor of PknH (results not shown). Thus we tested the capacity of O 6 -cyclohexylmethylguanine ( Figure 4A ) to interfere with the autokinase activity of eight M. tuberculosis STPKs in vitro. The catalytic domains of the kinases were purified as GST-fusion proteins [17] and incubated individually with [γ -
33 P]ATP in the absence or presence of 50 µM O 6 -cyclohexylmethylguanine. Figure 4 (A) shows that this compound selectively inhibited the various kinases. Whereas the drug did not appreciably alter the activity of PknA, PknB, PknF, PknK or PknL, it exhibited a potent inhibitory effect on PknH and PknE and completely abrogated the autophosphorylation activity of PknD. Comparative sequence analysis allowed grouping of the 11 M. tuberculosis kinases into three distinct homology clusters (PknA/B/L, PknF/I/J and PknD/E/H), while the two soluble enzymes (PknG and PknK) stand apart from all the others [2, 41] . Our results clearly indicate that O 6 -cyclohexylmethylguanine exhibits specific activity against the third group of kinases only, supporting the notion that PknD/E/H belong to the same clade. It also demonstrates the feasibility to design inhibitors that will target specifically one clade rather than another. This selectivity is of particular interest since signalling elements, including STPK, may represent a new class of attractive targets, and the expertise in designing such inhibitors for eukaryotic STPKs represents an intense research area [42] and could be exploited for the development of new antitubercular drugs. 
EmbR2 inhibits PknH-dependent phosphorylation of EmbR
It is known that activation of kinases often depends on regulatory processes involving phosphorylation/dephosphorylation through an autocatalytic mechanism. For instance, the activation loop is a major control element of an active/inactive conformational switch in numerous kinases [43] , and the conformation of the activation loop often depends on the phosphorylation state [44] . Based on structural studies, it is thought that the activation loop controls both the accessibility to the catalytic site and the binding of the substrate. Combining on-target dephosphorylation/MALDI-TOF-MS (matrix-assisted laser-desorption ionization-time-offlight MS) and LC-ESI-MS/MS (liquid chromatographyelectrospray ionization tandem MS) has recently allowed the identification of nine phosphorylation sites in PknH [34] resulting from autophosphorylation, a prerequisite for its kinase activity. Since EmbR2 inhibits autophosphorylation of PknH, PknHdependent phosphorylation of EmbR could be dependent on
Figure 5 PknH-dependent phosphorylation of EmbR is inhibited by EmbR2
Equal amounts of purified GST-PknH (0.3 µg) and EmbR (1 µg) were incubated with increasing concentrations (up to 3 µg) of EmbR2 with [γ - 33 P]ATP for 20 min at 37 • C. Samples were separated by SDS/PAGE and the effect of EmbR2 on PknH and EmbR phosphorylation was visualized by autoradiography. The upper panels represent the corresponding autoradiograms, whereas the lower panels reflect densitometric analysis. In the control experiment, EmbR2 was replaced by GST.
the presence of EmbR2. Figure 5 clearly shows a dosedependent inhibition of EmbR phosphorylation with increasing concentrations of EmbR2. However, when EmbR2 was replaced by an unrelated protein, for instance GST, there was no inhibitory effect on EmbR phosphorylation, thus demonstrating that the inhibitory effect was specific to EmbR2. These results suggest that, in the reaction mixture containing PknH and EmbR, EmbR2 inhibited the phosphorylation of EmbR by PknH, presumably because EmbR2 prevents the conversion of PknH from the inactive non-phosphorylated form into the active phosphorylated form. It is noteworthy that a similar mechanism of regulation has been reported in S. coelicolor A3(2), in which the KbpA protein binds to and inhibits autophosphorylation of AfsK as well as phosphorylation of AfsR, the substrate of AfsK [18] .
Concluding remarks
The cell wall of pathogenic mycobacteria undergoes continuous changes in the course of growth, intramacrophagic survival or during infection in response to environmental changes [45] , and many of the environmental stimuli are communicated within mycobacteria by sensor kinases present on the mycobacterial membrane [1] . PknH is unique to pathogenic mycobacteria, which is induced on infection of macrophages with M. tuberculosis [13] . The embCAB operon encoding arabinosyltransferases was identified as the cellular target of EmbR in M. tuberculosis [9] . PknHdependent phosphorylation of EmbR enhances the DNA-binding activity of EmbR towards promoter regions of embCAB genes. The consequent enhanced transcription of embC results in a higher ratio of LAM to LM (lipomannan) [9] , which are two major cell wall lipoglycans. These complex molecules are important determinants in the mycobacterial physiology and in the modulation of the host immune system during disease progression [46] . Furthermore, PknH expression modestly alters ethambutol resistance by virtue of its ability to increase the transcription of the embA and embB genes [9] . Together, this establishes that embCAB activation is controlled by EmbR phosphorylation and connects the LAM/LM ratio with the phosphorylation status of PknH. However, little is known with respect to the regulation processes controlling PknH activation. Although this could be achieved (at least partially) by phosphorylation/dephosphorylation via the action of the serine/threonine phosphatase PstP [16, 17] , the present study also suggests that EmbR2 could be a key regulator of PknH activation. We propose that PknH and EmbR form a pair participating in arabinan metabolism that can also be controlled by EmbR2, providing a novel mechanism of regulating the phosphorylation of EmbR via PknH. In summary, the present study describes an additional level of regulation of mycobacterial STPKs, which may explain how a limited number of kinases participate in many complex signalling pathways. It has been proposed that the PknH-mediated signalling pathways contribute to the regulation of bacillary load during the infection process [4] . Upon infection in mice, the M. tuberculosis H37Rv pknH mutant survived to a higher load in the mouse organs, especially during the chronic stage of infection, indicating that PknH plays a role in regulating bacillary load to facilitate adaptation to the host environment during the infection process. In this context, in vivo expression of EmbR2 in M. tuberculosis CDC1551 or in other pathogenic species such as M. bovis (which possesses an identical embR2 gene) could inhibit PknH activation and consequently increase the virulence phenotype of these strains. It remains to be determined whether EmbR2 plays an in vivo inhibitory role in a negative-feedback system in the PknH/EmbR regulatory pathway and contributes to survival and hypervirulence in pathogenic mycobacteria.
